BIOAGE LABS, INC. Key Metrics

2 years of history · ending 2025-12-31 · SEC EDGAR

Forensics

Three classic accounting-quality scores. F-Score (0-9, higher = better fundamentals); M-Score (>-1.78 flags possible manipulation); Z-Score (>2.99 = safe, <1.81 = distressed). Use together — single-score readings are noisy.

F-Score (Piotroski 0-9)

Z-Score (Altman; <1.81 = distress)

Per Share Metrics

Turnover & Efficiency Analysis (days)

Expense Ratios

Working Capital Analysis

Valuation Multiples

Enterprise Value Multiples

52-Week Range

Trailing Returns

ROIC vs WACC

Yields

Capital Deployment Yields

Liquidity & Leverage Ratios

Earnings Quality (OCF/NI · FCF/NI · Sloan Accruals)

EPS (Diluted)
$-2
Book Value Per Share
$8
Free Cash Flow Per Share
$-2
Cash Per Share
$5
Revenue Per Share
$0
OCF Per Share
$-2
Return on Equity
-27.1%
Return on Assets
-24.7%
Return on Invested Capital
-24.5%
Debt to Equity
0.00
Current Ratio
14.24
Quick Ratio
14.24
Asset Turnover
0.03
Days Sales Outstanding
31.20
R&D / Revenue
822.3%
SBC / Revenue
130.0%
Capex / Revenue
8.0%
Working Capital
$267M
Net Current Asset Value
$264M
Invested Capital
$272M
OCF / Net Income
1.01
FCF / Net Income
1.02
Accruals Ratio (Sloan)
0.3%
Net Debt
$-281M
Net Debt / EBITDA
3.04
Interest Coverage
-133.11
Cash Coverage
-117.11
Capex Coverage
-113.53
Tangible Common Equity
$272M
TCE / Total Assets
92.3%
NOPAT
$-73M
Cash ROIC
-27.6%
WC / Revenue
2964.5%
Capex / D&A
3.60
Reinvestment Rate
-0.6%
Stock Price (FY-end)
$13
Market Cap
$475M
P/S Ratio
52.85
P/B Ratio
1.75
P/TB Ratio
1.75
Enterprise Value
$194M
EV / Sales
21.60
FCF Yield
-17.3%
Shareholder Yield
-2.5%
R&D Yield
15.6%
Capex Yield
0.2%
Shares Variation (YoY)
235.0%
Beta (5Y)
0.92
Cost of Equity
9.1%
Cost of Debt (after tax)
74.7%
52W High
$14
52W Low
$3
Trailing Return 1Y
140.5%
F-Score (Piotroski)
3.00
Z-Score (Altman)
10.98

Earnings Forecasts

Per-quarter consensus estimates + actuals + beat/miss surprise. Sourced from Finnhub (Wall Street consensus aggregation).

Source caveat: Finnhub free tier returns the consensus mean only — analyst high / low / dispersion + analyst counts require a paid plan. A "$5.00 consensus" line above could mean "20 analysts at exactly $5" (high conviction) or "10 at $5.50, 10 at $4.50" (split). Treat single-line consensus accordingly.

EPS — Consensus vs Actual

Revenue — Consensus vs Actual

Stock Price on Earnings Dates